- Home
- WD vs IMVT Comparison
WD vs IMVT Comparison
Compare WD & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WD
- IMVT
- Stock Information
- Founded
- WD 1937
- IMVT N/A
- Country
- WD United States
- IMVT United States
- Employees
- WD N/A
- IMVT N/A
- Industry
- WD Finance: Consumer Services
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WD Finance
- IMVT Health Care
- Exchange
- WD Nasdaq
- IMVT Nasdaq
- Market Cap
- WD 3.3B
- IMVT 3.6B
- IPO Year
- WD 2010
- IMVT N/A
- Fundamental
- Price
- WD $83.10
- IMVT $21.27
- Analyst Decision
- WD Hold
- IMVT Strong Buy
- Analyst Count
- WD 3
- IMVT 12
- Target Price
- WD $106.67
- IMVT $45.90
- AVG Volume (30 Days)
- WD 220.3K
- IMVT 1.4M
- Earning Date
- WD 02-13-2025
- IMVT 02-06-2025
- Dividend Yield
- WD 3.21%
- IMVT N/A
- EPS Growth
- WD 0.31
- IMVT N/A
- EPS
- WD 3.19
- IMVT N/A
- Revenue
- WD $1,051,964,999.00
- IMVT N/A
- Revenue This Year
- WD N/A
- IMVT N/A
- Revenue Next Year
- WD $7.30
- IMVT N/A
- P/E Ratio
- WD $26.20
- IMVT N/A
- Revenue Growth
- WD 5.57
- IMVT N/A
- 52 Week Low
- WD $82.97
- IMVT $19.07
- 52 Week High
- WD $118.19
- IMVT $39.55
- Technical
- Relative Strength Index (RSI)
- WD 27.93
- IMVT 47.11
- Support Level
- WD $83.17
- IMVT $20.41
- Resistance Level
- WD $96.00
- IMVT $21.43
- Average True Range (ATR)
- WD 2.56
- IMVT 1.13
- MACD
- WD -0.92
- IMVT 0.23
- Stochastic Oscillator
- WD 1.00
- IMVT 54.52
About WD Walker & Dunlop Inc
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company's products consist of first mortgage loans, second trust loans, supplemental financings, construction loans, mezzanine loans, and bridge/interim loans. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).